DE69609501T2 - Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte - Google Patents

Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte

Info

Publication number
DE69609501T2
DE69609501T2 DE69609501T DE69609501T DE69609501T2 DE 69609501 T2 DE69609501 T2 DE 69609501T2 DE 69609501 T DE69609501 T DE 69609501T DE 69609501 T DE69609501 T DE 69609501T DE 69609501 T2 DE69609501 T2 DE 69609501T2
Authority
DE
Germany
Prior art keywords
sodium starch
starch glycolate
active substances
composition
products produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69609501T
Other languages
English (en)
Other versions
DE69609501D1 (de
Inventor
Fabio Carli
J Shah
Edward C Shinal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aptalis Pharma SRL
Original Assignee
Eurand International SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand International SpA filed Critical Eurand International SpA
Application granted granted Critical
Publication of DE69609501D1 publication Critical patent/DE69609501D1/de
Publication of DE69609501T2 publication Critical patent/DE69609501T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69609501T 1995-04-20 1996-04-17 Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte Expired - Lifetime DE69609501T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42543495A 1995-04-20 1995-04-20
PCT/IB1996/000492 WO1996032931A2 (en) 1995-04-20 1996-04-17 Composite with sodium starch glycolate as a support material and products thereof

Publications (2)

Publication Number Publication Date
DE69609501D1 DE69609501D1 (de) 2000-08-31
DE69609501T2 true DE69609501T2 (de) 2001-03-29

Family

ID=23686568

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69609501T Expired - Lifetime DE69609501T2 (de) 1995-04-20 1996-04-17 Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte

Country Status (11)

Country Link
EP (1) EP0822808B1 (de)
JP (1) JPH11503749A (de)
AT (1) ATE194909T1 (de)
AU (1) AU5658496A (de)
CA (1) CA2218486A1 (de)
DE (1) DE69609501T2 (de)
DK (1) DK0822808T3 (de)
ES (1) ES2149471T3 (de)
GR (1) GR3034617T3 (de)
PT (1) PT822808E (de)
WO (1) WO1996032931A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1295289B1 (it) * 1997-10-07 1999-05-04 Telos S R L Co-macinati per uso cosmetico e dermatologico
DE60205491T2 (de) * 2001-06-29 2006-06-01 Eurand Pharmaceuticals Ltd. Verfahren zur arzneimittelaktivierung mittels schwingmühle
CA2450907C (en) * 2001-06-29 2011-08-23 Eurand Pharmaceuticals Limited Process for activation of drugs in a vibrational mill
DE602004000260T2 (de) 2003-07-22 2006-08-24 Arena Pharmaceuticals, Inc., San Diego Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
JP5393677B2 (ja) 2007-08-15 2014-01-22 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ＨＴ２Ａセロトニン受容体に関連した障害の治療のための５−ＨＴ２Ａセロトニン受容体のモジュレーターとしてのイミダゾ［１，２−ａ］ピリジン誘導体
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US9034911B2 (en) 2008-10-28 2015-05-19 Arena Pharmaceuticals, Inc. Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
ITMI20120092A1 (it) * 2012-01-26 2013-07-27 Micro Macinazione S A Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
CA2989343A1 (en) 2015-06-12 2016-12-15 Yandong Wen Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder
BR112018000728A2 (pt) 2015-07-15 2018-09-04 Axovant Sciences Gmbh resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5132719A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Iyakuhinnoshorihoho
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
US5130140A (en) * 1989-09-14 1992-07-14 Hoeschst-Roussel Pharmaceuticals Inc. Method of making direct dry compressible acetaminophen composition

Also Published As

Publication number Publication date
WO1996032931A2 (en) 1996-10-24
DK0822808T3 (da) 2000-10-09
WO1996032931A3 (en) 1996-11-28
ES2149471T3 (es) 2000-11-01
JPH11503749A (ja) 1999-03-30
EP0822808A2 (de) 1998-02-11
AU5658496A (en) 1996-11-07
EP0822808B1 (de) 2000-07-26
PT822808E (pt) 2000-12-29
GR3034617T3 (en) 2001-01-31
ATE194909T1 (de) 2000-08-15
CA2218486A1 (en) 1996-10-24
DE69609501D1 (de) 2000-08-31

Similar Documents

Publication Publication Date Title
DE69609501T2 (de) Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte
UY24875A1 (es) Composiciones farmacéuticas conteniendo tetrahidrolipstatina
AU7915898A (en) Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration
AP1954A (en) Controlled release compositions comprising nimesulide.
AU7001001A (en) Modified forms of pharmacologically active agents and uses therefor
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
AU6329600A (en) Foot prosthesis
RU2001122708A (ru) Способы лечения рака яичника, поли (фосфоэфирные) композиции и способные подвергаться биологической деструкции изделия для этого предназначенные
ATE223712T1 (de) Pharmazeutische zusammensetzung von l-dopa ethyl ester
DE69433355D1 (de) Taxane ohne die c-9 oxo gruppe und diese enthaltende pharmazeutische präparate
IT1301966B1 (it) Composizioni farmaceutiche ad attivita' analgesica
BG103714A (en) Pararacetamol-containing tablet
HK1022265A1 (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
FR2729857B1 (fr) Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
TW200503689A (en) Pharmaceutical compositions of atorvastatin
HUP9901260A3 (en) Optically active phenylpyrimidine derivative as analgesic agent, process for producing it, pharmaceutical composition containing it and its intermediate
NZ515999A (en) Biologically active materials
EP0626170A3 (de) Stabilisierung pharmakologisch aktiver Verbindungen in Mitteln mit verzögerter Freisetzung.
DE69813263D1 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
AU5685300A (en) Solid preparations containing paroxetine
ES2165509T3 (es) Composiciones terapeuticas efervescentes.
WO1998036778A8 (en) Sustained drug delivery and compositions useful therefor

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: EURAND INTERNATIONAL S.P.A., MAILAND/MILANO, IT

8364 No opposition during term of opposition
R081 Change of applicant/patentee

Ref document number: 822808

Country of ref document: EP

Owner name: APTALIS PHARMA S.R.L., IT

Free format text: FORMER OWNER: EURAND INTERNATIONAL S.P.A., MAILAND/MILANO, IT

Effective date: 20110824

R082 Change of representative

Ref document number: 822808

Country of ref document: EP

Representative=s name: HOFFMANN - EITLE, 81925 MUENCHEN, DE

R082 Change of representative

Ref document number: 822808

Country of ref document: EP

Representative=s name: HOFFMANN - EITLE, 81925 MUENCHEN, DE